Cases & Deals

  • Home
  • Practices
  • Sterigenics International acquires Toxikon Europe NV

Share

Sterigenics International acquires Toxikon Europe NV

October 2017

Client(s) Sterigenics International LLC

Jones Day represented Sterigenics International LLC, the world’s leading, fully integrated protector of global health, in connection with its acquisition of Belgian-based Toxikon Europe NV, the European subsidiary of Toxikon Corporation, a Bedford, Massachusetts-based preclinical contract research organization. Toxikon Europe NV provides a suite of integrated analytical, material characterization, and microbiological services to the pharmaceutical, medical device, and biologics industries.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.